J. Kevin Massey is CEO of the Arlington Consulting Group, which provides healthcare technology innovation, quality improvement, strategy and program development/support. Massey has been a member of the advisory board for the National RX Drug Abuse & Heroin Summit since 2013 and has co-published articles and presents at numerous conferences as an expert. For over 25 years, Massey has served in management, executive and consulting capacities in the fields of public health, healthcare and financial services. Prior to the Arlington Consulting Group, he served as the Health Services & Court Compliance Administrator for Wellpath, which is a leading, national contracted provider of correctional healthcare services in the US. He lead an integrated clinical team of more than 100 professionals that served over 1,300 patients located onsite at the New Orleans Parrish Jail. Previously, as the Director of Strategic Business Development at the Community Health Center, Inc., he co-lead the development of clinical innovations that improved specialty healthcare access amongst underserved primary care patients across the US. Prior leadership roles include: Director of Violence and Injury Prevention in the State of Delaware, Department of Health where he lead health policy, clinical practice and executed broad-based prevention/population health programs, to include analyzing the PDMP; Chief Operating Officer at the Kent Community Health Center, a $20M outpatient primary care health center and Interim Director of Marketing/Community Engagement for United Healthcare, Delaware Community Medicaid Plan.